TRACON Pharmaceuticals Inc. (TCON) Declined -48.49% or -0.63 To Price $0.67 On Friday

TRACON Pharmaceuticals Inc. (TCON) declined -48.49% or -0.63 to $0.67. It is near 3.45 million shares traded, which is 608.78% compare to the average total volume 567098. The market cap of TCON is $20.02 million. The year to date change is 33.53%. The 52 week price range is from $0.5 to $3.2. Price of TCON have changed -6.47% during last week. It have changed -1.52% over last month, 58.54% over last 3 months, -28.96% over last 6 months and -53.57% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TCON is 1.25. It is 86.57% above current price. The 200-day Moving Averages for TCON is 1.63. It is 143.28% above current price. The 52-week High is 3.2. It is 377.61% from the current price. The 52-week Low is 0.5. It is -25.37% from current price.

There are some statistics of TCON. It is has market cap $20.02 million. The share outstanding is 29.90 million. The average volume is 567098. The percent of top 15 Institution holding is 62.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TCON is -185.44%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TCON is -92.93%.


Share this post